4.4 Article

SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway

Journal

ENDOCRINE-RELATED CANCER
Volume 29, Issue 2, Pages 47-58

Publisher

BIOSCIENTIFICA LTD
DOI: 10.1530/ERC-21-0256

Keywords

SREBP1; invasion; thyroid cancer; lipid metabolism

Funding

  1. Ministry of Science and Technology of Taiwan [MOST-107-2314-B-195-001-MY3, MOST110-2314-B-195-018-MY3]
  2. MacKay Memorial Hospital [MMH-11008, MMH-E-110-10]

Ask authors/readers for more resources

Aberrant lipid metabolism plays a crucial role in providing energy, building materials, and oxidative stress resistance to cancer cells. This study found that high expression of SREBP1 in invasive thyroid cancer is associated with extrathyroidal extension, advanced disease stage, and shorter disease-specific survival. SREBP1 overexpression promotes cancer cell invasiveness through the upregulation of CYR61/CTGF via the Hippo-YAP pathway.
Aberrant lipid metabolism provides bioenergetic, biosynthetic, and redox supplies to cancer cells. Previous studies have reported differential lipid profiling in thyroid malignancies. Sterol regulatory element-binding protein 1 (SREBP1), encoded by the SREBF1 gene, is a master regulator of cellular lipid homeostasis. The clinical and functional significance of SREBP1 in thyroid cancer is not well understood. Here, we showed that SREBP1 expression is significantly upregulated in invasive thyroid cancer than in normal thyroid tissue or benign thyroid nodules. High tumoral SREBP1 expression was associated with extrathyroidal extension, advanced disease stage, and shorter disease-specific survival in patients with differentiated thyroid cancer. SREBP1 overexpression significantly increased the oxygen consumption rate, filopodia formation, and migratory and invasive capacities of thyroid cancer cells. Knockdown of SREBF1 or treatment with an SREBP1 activation inhibitor fatostatin had the opposite effect. RNA-Seq analysis showed that modulation of SREBP1 expression was accompanied by corresponding changes in the expression of epithelial-mesenchymal transition markers and CYR61/CTGF. SREBP1-facilitated cell invasion could be abrogated by treatment with a YAP inhibitor such as verteporfin or genetic silencing of CYR61 or CTGF. In summary, SREBP1 upregulation can be used as a prognostic indicator for thyroid cancer and SREBP1 overexpression is involved in cancer invasiveness, at least partly, through upregulation of CYR61/CTGF via the Hippo-YAP pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available